04 Feb 2019

Medical product alert: falsified rabies vaccine - Philippines

A report of falsified rabies vaccine circulating in the Philippines Medical product alert: falsified rabies vaccine - Philippines

On 30 January 2019, the World Health Organization (WHO) issued a Medical Product Alert concerning falsified Verorab® rabies vaccine circulating in the Philippines. The manufacturer of the authentic Verorab® product has confirmed that they did not manufacture the falsified vaccines. WHO has not received reports of adverse reactions to the falsified product at the time of this report [1].

Advice for travellers

Authentic rabies vaccine is used to protect those at risk of exposure to rabies (pre-exposure), or to prevent rabies developing following the bite of an animal suspected of having the disease (post- exposure prophylaxis).

Country specific information about the risk of rabies can be found on our Country Information pages and Outbreak Surveillance database.

Further advice on the worldwide risk of rabies, including the action you should take if bitten, licked or scratched by an animal in a country where rabies is known or presumed to occur, is available from NaTHNaC; Worldwide risk of rabies.

If you recently received a course vaccine in the Philippines after an exposure or for other reasons, you should contact your doctor or a local travel clinic for advice.

Advice for health professionals

This notice applies to the circulation of a falsified product in the Philippines only.

Health professionals with concerns about a traveller who has received this falsified product can call Public Health England: Rabies and Immunoglobulin Service.

The Sanofi Pasteur product Verorab® distributed in the United Kingdom is used with the approval of the Medicines and Healthcare products Regulatory Agency (MHRA).

Resources

Country focus: India

Most travellers have a safe trip, however, there are potential health hazards in India Read more

Reminder: Annual Return for Yellow Fever Vaccination Centres (YFVC) now due

Important notice to all YFVC in England, Wales and Northern Ireland Read more

Country specific Japanese Encephaltitis risk and recommendations 2019 updated

Updated Japanese encephalitis risk and country specific recommendations Read more

NaTHNaC Webinar: update

Getting to grips with common clinical queries to the advice line Read more
Back to Top

VIEW FULL INDEX